Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia Resulting from SIADH Following Pituitary Surgery.
Andrea KleindienstSimeon GeorgievSven Martin SchlafferMichael BuchfelderPublished in: Journal of the Endocrine Society (2020)
Tolvaptan at a moderate dose is more effective than fluid restriction in the treatment of SIADH. Overcorrection of serum sodium may be a side effect of tolvaptan even at low doses.